Impact of obstructive sleep apnea treatment in patients with paroxysmal atrial fibrillation.

Not Applicable

• Conditions: Atrial Fibrillation; Sleep Apnoea; Cardiovascular - Other cardiovascular diseases; Respiratory - Sleep apnoea

• Registration Number: ACTRN12616000262404
• Lead Sponsor: Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Patients with AF.
Patients with at least moderate obstructive sleep apnea defined AHI of 15 or greater.

Exclusion Criteria

Significant pulmonary disease
Life expectancy < 24 months
Severely elevated Epworth Sleepiness Scores that may pose driving risk
Involvement in another trial that will compromise this trial
Reversible cause of AF

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in AF burden (as a percentage of time in AF) assessed by implanted loop recorder or Holter monitor.[3, 6, 9 and 12 months];Change in AF burden (as total time in AF) assessed by implanted loop recorder or Holter monitor.[3, 6, 9 and 12 months]